- Home
- IMMX vs OWLT Comparison
IMMX vs OWLT Comparison
Compare IMMX & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- OWLT
- Stock Information
- Founded
- IMMX 2014
- OWLT 2013
- Country
- IMMX United States
- OWLT United States
- Employees
- IMMX N/A
- OWLT N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IMMX Health Care
- OWLT Health Care
- Exchange
- IMMX Nasdaq
- OWLT Nasdaq
- Market Cap
- IMMX 61.1M
- OWLT 79.1M
- IPO Year
- IMMX 2021
- OWLT N/A
- Fundamental
- Price
- IMMX $2.17
- OWLT $4.70
- Analyst Decision
- IMMX Strong Buy
- OWLT
- Analyst Count
- IMMX 1
- OWLT 0
- Target Price
- IMMX $7.00
- OWLT N/A
- AVG Volume (30 Days)
- IMMX 268.7K
- OWLT 55.8K
- Earning Date
- IMMX 11-12-2024
- OWLT 11-13-2024
- Dividend Yield
- IMMX N/A
- OWLT N/A
- EPS Growth
- IMMX N/A
- OWLT N/A
- EPS
- IMMX N/A
- OWLT N/A
- Revenue
- IMMX N/A
- OWLT $78,575,000.00
- Revenue This Year
- IMMX N/A
- OWLT $40.64
- Revenue Next Year
- IMMX $200.00
- OWLT $20.09
- P/E Ratio
- IMMX N/A
- OWLT N/A
- Revenue Growth
- IMMX N/A
- OWLT 74.76
- 52 Week Low
- IMMX $1.26
- OWLT $3.20
- 52 Week High
- IMMX $7.50
- OWLT $7.50
- Technical
- Relative Strength Index (RSI)
- IMMX 53.37
- OWLT 47.51
- Support Level
- IMMX $1.88
- OWLT $4.41
- Resistance Level
- IMMX $2.44
- OWLT $5.39
- Average True Range (ATR)
- IMMX 0.32
- OWLT 0.34
- MACD
- IMMX -0.02
- OWLT -0.04
- Stochastic Oscillator
- IMMX 34.94
- OWLT 34.91
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About OWLT Owlet Inc.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.